Sunbelt Securities, Inc. Neurocrine Biosciences Inc Transaction History
Sunbelt Securities, Inc.
- $836 Million
- Q1 2024
A detailed history of Sunbelt Securities, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 292 shares of NBIX stock, worth $42,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
292
Previous 325
10.15%
Holding current value
$42,541
Previous $42,000
4.76%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
94.5MCall Options Held
472KPut Options Held
245K-
Black Rock Inc. New York, NY13.8MShares$2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.45 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$581 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$334 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$328 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...